Anaphylaxis
A Preventable Threat in a World of Rising Allergies
DOI:
https://doi.org/10.70552/pjaai.25.1.15045Abstract
As the global burden of allergies grows, so does the shadow of anaphylaxis—an acute, life-threatening hypersensitivity reaction that demands swift recognition and management. World Allergy Week 2025, led by the World Allergy Organization (WAO), brings the spotlight to this critical issue under the timely theme: "Anaphylaxis: A Preventable Threat."
This year's campaign is not just a call for awareness; it is a charge to action—especially for allergists—to prevent avoidable tragedies through vigilance, education, and evidence-based care.
References
Golden DBK, Wang J, Waserman S, et al. Anaphylaxis: a 2023 practice parameter update. Ann Allergy Asthma Immunol. 2024;132(2):124-76. https://pubmed.ncbi.nlm.nih.gov/38108678 https://doi.org/10.1016/j.anai.2023.09.015 DOI: https://doi.org/10.1016/j.anai.2023.09.015
Turner PJ, Campbell DE, Motosue MS, Campbell RL. Global Trends in anaphylaxis epidemiology and clinical implications. J Allergy Clin Immunol Pract. 2020;8(4):1169-76. https://pubmed.ncbi.nlm.nih.gov/31786255 https://pmc.ncbi.nlm.nih.gov/articles/PMC7152797 https://doi.org/10.1016/j.jaip.2019.11.027 DOI: https://doi.org/10.1016/j.jaip.2019.11.027
Dribin TE, Waserman S, Turner PJ. Who needs epinephrine? anaphylaxis, autoinjectors, and parachutes. J Allergy Clin Immunol Pract. 2023;11(4):1036-46. https://pubmed.ncbi.nlm.nih.gov/36796511 https://pmc.ncbi.nlm.nih.gov/articles/PMC10259181 https://doi.org/10.1016/j.jaip.2023.02.002 DOI: https://doi.org/10.1016/j.jaip.2023.02.002
Tanno LK, Worm M, Ebisawa M, Ansotegui IJ, et al. Global disparities in availability of epinephrine auto-injectors. World Allergy Organ J. 2023;16(10):100821. https://pubmed.ncbi.nlm.nih.gov/37915955 https://pmc.ncbi.nlm.nih.gov/articles/PMC10616381 https://doi.org/10.1016/j.waojou.2023.100821 DOI: https://doi.org/10.1016/j.waojou.2023.100821
Cardona V, Ansotegui IJ, Ebisawa M, et al. World allergy organization anaphylaxis guidance 2020. World Allergy Organ J. 2020;13(10):100472. https://pubmed.ncbi.nlm.nih.gov/33204386 PMCID: PMC7607509 https://doi.org/10.1016/j.waojou.2020.100472 DOI: https://doi.org/10.1016/j.waojou.2020.100472
Ichikawa M, Kuriyama A, Urushidani S, Ikegami T. Incidence and timing of biphasic anaphylactic reactions: a retrospective cohort study. Acute Med Surg. 2021;8(1):e689. https://pubmed.ncbi.nlm.nih.gov/34354840 https://pmc.ncbi.nlm.nih.gov/articles/PMC8323456 https://doi.org/10.1002/ams2.689 DOI: https://doi.org/10.1002/ams2.689
Fleischer DM, Li HH, Talreja N, et al. Pharmacokinetics and pharmacodynamics of neffy, epinephrine nasal spray, in pediatric allergy patients. J Allergy Clin Immunol Pract. 2025;13(6):1335-41.e1. https://pubmed.ncbi.nlm.nih.gov/40120808 https://doi.org/10.1016/j.jaip.2025.03.019 DOI: https://doi.org/10.1016/j.jaip.2025.03.019
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Julia C. De Leon, MD
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
